Cargando…
Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy
BACKGROUND: The incidence of oesophageal adenocarcinoma is increasing worldwide but survival remains poor. Neoadjuvant chemotherapy may improve survival, but targeting treatment to patients who respond to chemotherapy could be improved by the availability of markers of response. This study sought pr...
Autores principales: | Kelly, P, Appleyard, V, Murray, K, Paulin, F, Lamont, D, Baker, L, Suttie, S, Exon, D, Thompson, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906736/ https://www.ncbi.nlm.nih.gov/pubmed/20551956 http://dx.doi.org/10.1038/sj.bjc.6605741 |
Ejemplares similares
-
Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer
por: Kelly, P, et al.
Publicado: (2012) -
Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
por: Komatsu, S, et al.
Publicado: (2011) -
Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas
por: Bain, G H, et al.
Publicado: (2014) -
Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma
por: Miyagaki, H, et al.
Publicado: (2012) -
Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma
por: Hirajima, S, et al.
Publicado: (2013)